🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Several professionals said the popularity for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down violative material and prohibited related keywords and search suggestions. The company stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of slimming results, positive testimonials and detailed guides for preparing or injecting at home.

After moments of joining one group, a vendor posted contact information, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Inside these communities, messages display dark colored packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may subject users to possibly serious medical dangers”.